SANOFI (1SAN.MI) Stock Fundamental Analysis
BIT:1SAN - Euronext Milan - FR0000120578 - Common Stock - Currency: EUR
Taking everything into account, 1SAN scores 5 out of 10 in our fundamental rating. 1SAN was compared to 50 industry peers in the Pharmaceuticals industry. 1SAN scores excellent on profitability, but there are some minor concerns on its financial health. 1SAN has a decent growth rate and is not valued too expensively. Finally 1SAN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
1SAN had positive earnings in the past year.
In the past year 1SAN had a positive cash flow from operations.
1SAN had positive earnings in each of the past 5 years.
Each year in the past 5 years 1SAN had a positive operating cash flow.
1.2 Ratios
1SAN's Return On Assets of 7.77% is fine compared to the rest of the industry. 1SAN outperforms 68.00% of its industry peers.
With a decent Return On Equity value of 13.83%, 1SAN is doing good in the industry, outperforming 64.00% of the companies in the same industry.
The Return On Invested Capital of 1SAN (13.31%) is better than 74.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1SAN is significantly below the industry average of 14.77%.
The 3 year average ROIC (7.31%) for 1SAN is below the current ROIC(13.31%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 13.83% | ||
| ROIC | 13.31% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
1SAN has a Profit Margin of 14.84%. This is in the better half of the industry: 1SAN outperforms 72.00% of its industry peers.
In the last couple of years the Profit Margin of 1SAN has grown nicely.
1SAN has a better Operating Margin (23.19%) than 64.00% of its industry peers.
In the last couple of years the Operating Margin of 1SAN has grown nicely.
1SAN's Gross Margin of 70.78% is in line compared to the rest of the industry. 1SAN outperforms 56.00% of its industry peers.
In the last couple of years the Gross Margin of 1SAN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.19% | ||
| PM (TTM) | 14.84% | ||
| GM | 70.78% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1SAN is creating some value.
1SAN has about the same amout of shares outstanding than it did 1 year ago.
1SAN has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for 1SAN has been reduced compared to a year ago.
2.2 Solvency
1SAN has a debt to FCF ratio of 2.72. This is a good value and a sign of high solvency as 1SAN would need 2.72 years to pay back of all of its debts.
1SAN has a better Debt to FCF ratio (2.72) than 78.00% of its industry peers.
1SAN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
1SAN's Debt to Equity ratio of 0.18 is fine compared to the rest of the industry. 1SAN outperforms 74.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 2.72 | ||
| Altman-Z | N/A |
ROIC/WACC1.78
WACC7.47%
2.3 Liquidity
A Current Ratio of 1.37 indicates that 1SAN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.37, 1SAN is in line with its industry, outperforming 52.00% of the companies in the same industry.
A Quick Ratio of 0.69 indicates that 1SAN may have some problems paying its short term obligations.
1SAN has a worse Quick ratio (0.69) than 74.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 0.69 |
3. Growth
3.1 Past
1SAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.52%.
Measured over the past 5 years, 1SAN shows a small growth in Earnings Per Share. The EPS has been growing by 5.10% on average per year.
Looking at the last year, 1SAN shows a small growth in Revenue. The Revenue has grown by 5.52% in the last year.
Measured over the past years, 1SAN shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
EPS 1Y (TTM)-0.52%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%0.56%
Revenue 1Y (TTM)5.52%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-5.44%
3.2 Future
1SAN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.73% yearly.
The Revenue is expected to grow by 4.59% on average over the next years.
EPS Next Y8.37%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
EPS Next 5Y7.73%
Revenue Next Year1.53%
Revenue Next 2Y4.25%
Revenue Next 3Y4.83%
Revenue Next 5Y4.59%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.76 indicates a reasonable valuation of 1SAN.
Compared to the rest of the industry, the Price/Earnings ratio of 1SAN indicates a somewhat cheap valuation: 1SAN is cheaper than 78.00% of the companies listed in the same industry.
1SAN is valuated cheaply when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
1SAN is valuated reasonably with a Price/Forward Earnings ratio of 9.07.
Based on the Price/Forward Earnings ratio, 1SAN is valued cheaper than 82.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of 1SAN to the average of the S&P500 Index (35.33), we can say 1SAN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.76 | ||
| Fwd PE | 9.07 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1SAN.
1SAN's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.05 | ||
| EV/EBITDA | 11.02 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1SAN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.29
PEG (5Y)2.11
EPS Next 2Y9.02%
EPS Next 3Y8.18%
5. Dividend
5.1 Amount
1SAN has a Yearly Dividend Yield of 4.66%, which is a nice return.
Compared to an average industry Dividend Yield of 3.00, 1SAN pays a better dividend. On top of this 1SAN pays more dividend than 86.00% of the companies listed in the same industry.
1SAN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.66% |
5.2 History
The dividend of 1SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1SAN pays out 46.28% of its income as dividend. This is a bit on the high side, but may be sustainable.
1SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP46.28%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
BIT:1SAN (7/15/2025, 7:00:00 PM)
82.75
-0.25 (-0.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners40.34%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap201.50B
Analysts79.33
Price Target115.93 (40.1%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.66% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP46.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.92%
Min EPS beat(2)-2.18%
Max EPS beat(2)6.02%
EPS beat(4)3
Avg EPS beat(4)5.51%
Min EPS beat(4)-2.18%
Max EPS beat(4)14.5%
EPS beat(8)5
Avg EPS beat(8)2.86%
EPS beat(12)8
Avg EPS beat(12)3.25%
EPS beat(16)12
Avg EPS beat(16)3.85%
Revenue beat(2)0
Avg Revenue beat(2)-2.93%
Min Revenue beat(2)-4.57%
Max Revenue beat(2)-1.3%
Revenue beat(4)2
Avg Revenue beat(4)-0.12%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.47%
Revenue beat(12)6
Avg Revenue beat(12)19.07%
Revenue beat(16)10
Avg Revenue beat(16)28.26%
PT rev (1m)-4.42%
PT rev (3m)-1.56%
EPS NQ rev (1m)-1.21%
EPS NQ rev (3m)-5.58%
EPS NY rev (1m)0%
EPS NY rev (3m)0.08%
Revenue NQ rev (1m)-0.86%
Revenue NQ rev (3m)-4.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.76 | ||
| Fwd PE | 9.07 | ||
| P/S | 2.92 | ||
| P/FCF | 26.05 | ||
| P/OCF | 18.43 | ||
| P/B | 2.72 | ||
| P/tB | 19.63 | ||
| EV/EBITDA | 11.02 |
EPS(TTM)7.69
EY9.29%
EPS(NY)9.13
Fwd EY11.03%
FCF(TTM)3.18
FCFY3.84%
OCF(TTM)4.49
OCFY5.42%
SpS28.36
BVpS30.42
TBVpS4.22
PEG (NY)1.29
PEG (5Y)2.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 13.83% | ||
| ROCE | 16.06% | ||
| ROIC | 13.31% | ||
| ROICexc | 14.47% | ||
| ROICexgc | 47.61% | ||
| OM | 23.19% | ||
| PM (TTM) | 14.84% | ||
| GM | 70.78% | ||
| FCFM | 11.2% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexcg growth 3Y-13.63%
ROICexcg growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-ScoreN/A
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 2.72 | ||
| Debt/EBITDA | 0.68 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 55.78% | ||
| Profit Quality | 75.5% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 0.69 | ||
| Altman-Z | N/A |
F-ScoreN/A
WACC7.47%
ROIC/WACC1.78
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.52%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%0.56%
EPS Next Y8.37%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
EPS Next 5Y7.73%
Revenue 1Y (TTM)5.52%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-5.44%
Revenue Next Year1.53%
Revenue Next 2Y4.25%
Revenue Next 3Y4.83%
Revenue Next 5Y4.59%
EBIT growth 1Y7.75%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year34.08%
EBIT Next 3Y14.6%
EBIT Next 5Y10.46%
FCF growth 1Y-19.94%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y-11.47%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%